REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 166 filers reported holding REGENXBIO INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $132,116,027 | -20.1% | 8,026,490 | -2.9% | 0.00% | -20.0% |
Q2 2023 | $165,296,751 | +8.7% | 8,268,972 | +2.8% | 0.01% | +25.0% |
Q1 2023 | $152,051,338 | +0.3% | 8,040,790 | +20.3% | 0.00% | -20.0% |
Q4 2022 | $151,646,417 | -12.4% | 6,686,350 | +2.1% | 0.01% | -16.7% |
Q3 2022 | $173,151,000 | +5.8% | 6,551,276 | -1.2% | 0.01% | +20.0% |
Q2 2022 | $163,716,000 | -25.1% | 6,628,123 | +0.6% | 0.01% | -16.7% |
Q1 2022 | $218,683,000 | +1.8% | 6,588,815 | +0.3% | 0.01% | +20.0% |
Q4 2021 | $214,884,000 | -19.4% | 6,571,438 | +3.3% | 0.01% | -28.6% |
Q3 2021 | $266,688,000 | +10.7% | 6,361,803 | +2.6% | 0.01% | 0.0% |
Q2 2021 | $240,913,000 | +12.0% | 6,201,101 | -1.6% | 0.01% | +16.7% |
Q1 2021 | $215,030,000 | -12.8% | 6,304,040 | +16.0% | 0.01% | -25.0% |
Q4 2020 | $246,457,000 | +58.3% | 5,433,372 | -3.9% | 0.01% | +33.3% |
Q3 2020 | $155,671,000 | -23.8% | 5,656,642 | +2.0% | 0.01% | -25.0% |
Q2 2020 | $204,269,000 | +25.3% | 5,546,276 | +10.2% | 0.01% | 0.0% |
Q1 2020 | $163,024,000 | -23.9% | 5,034,689 | -3.7% | 0.01% | 0.0% |
Q4 2019 | $214,227,000 | +16.9% | 5,228,880 | +1.5% | 0.01% | 0.0% |
Q3 2019 | $183,319,000 | -29.3% | 5,149,431 | +2.0% | 0.01% | -27.3% |
Q2 2019 | $259,270,000 | -7.2% | 5,047,103 | +3.5% | 0.01% | -8.3% |
Q1 2019 | $279,514,000 | +38.2% | 4,877,215 | +1.1% | 0.01% | +20.0% |
Q4 2018 | $202,322,000 | -43.3% | 4,822,962 | +2.0% | 0.01% | -33.3% |
Q3 2018 | $356,893,000 | +17.9% | 4,727,045 | +12.1% | 0.02% | +7.1% |
Q2 2018 | $302,671,000 | +356.5% | 4,218,413 | +89.9% | 0.01% | +366.7% |
Q1 2018 | $66,296,000 | -12.7% | 2,220,966 | -2.8% | 0.00% | -25.0% |
Q4 2017 | $75,960,000 | -23.2% | 2,284,506 | -23.9% | 0.00% | -20.0% |
Q3 2017 | $98,951,000 | +76.2% | 3,003,039 | +5.6% | 0.01% | +66.7% |
Q2 2017 | $56,148,000 | +22.2% | 2,843,025 | +19.4% | 0.00% | 0.0% |
Q1 2017 | $45,945,000 | +48777.7% | 2,380,591 | +47115.2% | 0.00% | – |
Q4 2016 | $94,000 | +1.1% | 5,042 | -23.7% | 0.00% | – |
Q3 2016 | $93,000 | +138.5% | 6,604 | +35.4% | 0.00% | – |
Q2 2016 | $39,000 | +3800.0% | 4,878 | +4635.9% | 0.00% | – |
Q1 2016 | $1,000 | -50.0% | 103 | +3.0% | 0.00% | – |
Q4 2015 | $2,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |